AbbVie (NYSE:ABBV) Price Target Raised to $190.00 at UBS Group
AbbVie (NYSE:ABBV – Get Free Report) had its price target lifted by equities researchers at UBS Group from $181.00 to $190.00 in a note issued to investors on Monday,Benzinga reports. The brokerage ...
Guggenheim Raises AbbVie (NYSE:ABBV) Price Target to $214.00
AbbVie (NYSE:ABBV – Get Free Report) had its price target upped by stock analysts at Guggenheim from $212.00 to $214.00 in a ...
Analysts reset AbbVie stock price target after earnings
For the full year 2025, the North Chicago company forecasts adjusted earnings per share of $12.12 to $12.32, in line with the ...